Product
Antiretroviral
2 clinical trials
8 indications
Indication
HIV-1 infectionIndication
Adverse Reaction to Antiviral DrugsIndication
Vascular DiseasesIndication
Cardiovascular AbnormalitiesIndication
Adipose Tissue AbnormalityIndication
Body Weight ChangesIndication
Body Fat DisorderIndication
HIV-Associated Lipodystrophy SyndromeClinical trial
A Phase 3b Randomised, Multicentre, Open-label Study Evaluating the Effectiveness of Switching to Two-monthly Long-acting Injectable Cabotegravir and Rilpivirine From First-line Oral Antiretroviral Therapy in HIV-1 Positive Virologically Suppressed Adults With a History of, or at Risk of, Sub-optimal HIV Control in Sub-Saharan AfricaStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
Contribution of the Integrase Inhibitor Dolutegravir to Obesity and Cardiovascular Disease in Persons Living With HIVStatus: Completed, Estimated PCD: 2022-06-17